NIH’s $110M Women’s Health Investment – Join PMWC 2025’s Women’s Health Track
Have you heard about the Historic $110M NIH Investment in Women’s Health? Following the NIH’s announcement of this ARPA-H funding, the PMWC 2025 Silicon Valley (Feb 5-7 Program) Women’s Health Track is primed to spotlight innovations that align with this transformative support.
The Dawn of Digital Biology: Jensen Huang’s (NVIDIA) Vision for AI in Healthcare at PMWC25
In a world where technology and healthcare converge, the visionary leadership of Jensen Huang, the CEO of NVIDIA is pioneering a revolution that could redefine our approach to medicine and biology. We are thrilled to announce that Jensen Huang will be the Luminary honoree at the PMWC 2025 Silicon Valley track on AI and Data Science in Research and Development in Track 2 on February 7th (View the full February 5-7 Silicon Valley Program).
Interview Questions for Michael E. Phelps, UCLA
Given the significant advancements in PET radiopharmaceuticals over the past decade, what do you see as the most promising areas for future development?
Interview Questions for Kari Stefansson, CEO of deCODE Genetics
Can you share details about a current project at deCODE that excites you the most, whether in multiomics or another area of research?
Interview Questions for Ida Sim
Your work with JupyterHealth is pioneering the secure collection and computation of health data from various sources. Could you share how JupyterHealth is currently being implemented in real-world healthcare
Pioneering Minds Unite: Crystal Mackall, Drew Weissman, David R. Liu, Ira Mellman at PMWC25 CGT Oncology Track
We are thrilled to invite you to the Cell and Gene Therapy in Oncology Track at the upcoming Precision Medicine World Conference (PMWC) 2025 Silicon Valley – Feb 5-7. This track offers a unique opportunity to witness pioneering research and collaborative efforts that are reshaping the landscape of cancer treatment through innovative cell and gene therapies.
Interview Questions for Victor E. Velculescu
1. Integration of Liquid Biopsies:
“Given the rapid advancements in liquid biopsy technologies, including your development of DELFI, how do you envision their integration into routine clinical practice? Considering the current limitations, what
Interview Questions for Nicola Aceto
1. Your research has significantly advanced the understanding of circulating tumor cell (CTC) clusters in the bloodstream. Can you elaborate on the mechanisms that promote the formation of these clusters
Join CDC & KOLs on Mpox, H5N1, & more at PMWC25!
Amid growing global concerns over infectious disease outbreaks like Mpox, the urgency for cutting-edge diagnostic and therapeutic innovations has never been greater. Join us at PMWC 2025, where world-renowned experts will share the latest advancements in precision diagnostics and public health solutions.
Just Published: Groundbreaking AI Model for Cancer Diagnosis by Dr. Isaac Kohane – More at PMWC 2025
Dr. Isaac Kohane and his team have just published in Nature a groundbreaking research in cancer diagnosis using AI, introducing a new model that significantly outperforms current methods. This foundation model for clinical histopathology, trained on over 60,000 pathology slides and validated across 24 hospitals, sets a new standard for cancer diagnosis and prognosis.
